Follow
Associate Prof Mourad Tayebi
Associate Prof Mourad Tayebi
WSU
Verified email at WESTERNSYDNEY.EDU.AU
Title
Cited by
Cited by
Year
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
AR White, P Enever, M Tayebi, R Mushens, J Linehan, S Brandner, ...
Nature 422 (6927), 80-83, 2003
6072003
Regional heterogeneity of cellular prion protein isoforms in the mouse brain
V Beringue, G Mallinson, M Kaisar, M Tayebi, Z Sattar, G Jackson, ...
Brain 126 (9), 2065-2073, 2003
1662003
Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus
UK Adhikari, M Tayebi, MM Rahman
Journal of immunology research 2018, 2018
1222018
Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro
C Bate, M Tayebi, A Williams
Molecular Neurodegeneration 3, 1-9, 2008
862008
PrPSc binding antibodies are potent inhibitors of prion replication in cell lines
V Beringue, D Vilette, G Mallinson, F Archer, M Kaisar, M Tayebi, ...
Journal of Biological Chemistry 279 (38), 39671-39676, 2004
852004
Protein conformation significantly influences immune responses to prion protein
A Khalili-Shirazi, S Quaratino, M Londei, L Summers, M Tayebi, ...
The Journal of Immunology 174 (6), 3256-3263, 2005
592005
A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines
DR Jones, WA Taylor, C Bate, M David, M Tayebi
PloS one 5 (3), e9804, 2010
522010
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients
MA David, M Tayebi
Frontiers in neurology 5, 89415, 2014
512014
Phospholipase A2inhibitors protect against prion and Aβ mediated synapse degeneration
C Bate, M Tayebi, A Williams
Molecular neurodegeneration 5, 1-12, 2010
482010
Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2activation
C Bate, M Tayebi, A Williams
BMC biology 6, 1-10, 2008
422008
Potential candidate camelid antibodies for the treatment of protein-misfolding diseases
MA David, DR Jones, M Tayebi
Journal of Neuroimmunology 272 (1-2), 76-85, 2014
412014
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ...
Database 2019, 2019
352019
Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity
C Bate, M Tayebi, L Diomede, M Salmona, A Williams
PLoS One 4 (12), e8221, 2009
332009
Immunohistochemical validation of spontaneously arising canine osteosarcoma as a model for human osteosarcoma
AA Al-Khan, HJ Gunn, MJ Day, M Tayebi, SD Ryan, CA Kuntz, ES Saad, ...
Journal of comparative pathology 157 (4), 256-265, 2017
322017
Age-specific retinal and cerebral immunodetection of amyloid-β plaques and oligomers in a rodent model of Alzheimer’s disease
U Habiba, S Merlin, JKH Lim, VHY Wong, CTO Nguyen, JW Morley, ...
Journal of Alzheimer's Disease 76 (3), 1135-1150, 2020
302020
Detection of retinal and blood Aβ oligomers with nanobodies
U Habiba, J Descallar, F Kreilaus, UK Adhikari, S Kumar, JW Morley, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021
272021
The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication
C Bate, M Tayebi, A Williams
Biochemical Journal 428 (1), 95-101, 2010
272010
Unswitched immunoglobulin M response prolongs mouse survival in prion disease
M Tayebi, J Collinge, S Hawke
Journal of general virology 90 (3), 777-782, 2009
252009
Canine mixed mammary tumour as a model for human breast cancer with osseous metaplasia
ES Saad, KM Milley, AA Al-Khan, JS Nimmo, B Bacci, M Tayebi, MJ Day, ...
Journal of comparative pathology 156 (4), 352-365, 2017
202017
PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers
M Tayebi, DR Jones, WA Taylor, BF Stileman, C Chapman, D Zhao, ...
PLoS One 6 (5), e19998, 2011
202011
The system can't perform the operation now. Try again later.
Articles 1–20